β-Fibrinogen Gene −455G/A Polymorphism and Coronary Heart Disease Incidence The Atherosclerosis Risk in Communities (ARIC) Study

This publication has 28 references indexed in Scilit:

• Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
  JAMA, 1998
• Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease
  Circulation, 1997
• β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction
  Circulation, 1996
• Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A−455 (HaeIII), C/T−148 (HindIII/AluI), T/G+1689 (AvaII), andBclI (β-fibrinogen) andTaqI (α-fibrinogen), and their detection by PCR
  Human Mutation, 1994
• The Role of β-Fibrinogen Genotype in Determining Plasma Fibrinogen Levels in Young Survivors of Myocardial Infarction and Healthy Controls from Sweden
  Thrombosis and Haemostasis, 1993
• Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Variation in the Promoter Region of the β Fibrinogen Gene Is Associated with Plasma Fibrinogen Levels in Smokers and Non-Smokers
  Thrombosis and Haemostasis, 1991
• Fibrinogen and risk of cardiovascular disease. The Framingham Study
  JAMA, 1987
• HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
  The Lancet, 1986
• Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
  New England Journal of Medicine, 1984